We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

73 hedge funds and large institutions have $854M invested in Tempest Therapeutics in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 3

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

250% more capital invested

Capital invested by funds: $244M → $854M (+$610M)

38% more funds holding

Funds holding: 53 → 73 (+20)

36% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 14

Holders
73
Holders Change
+20
Holders Change %
+37.74%
% of All Funds
1.95%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.13%
New
25
Increased
19
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$18.5M
2
JHIU
Janus Henderson Investors US
Colorado
+$8.71M
3
CAM
Cormorant Asset Management
Massachusetts
+$5.79M
4
HCM
Highbridge Capital Management
New York
+$4.76M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.03M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$12.7M
2
EA
Emerald Advisers
Pennsylvania
-$4.1M
3
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$3.37M
4
NIP
Nicholas Investment Partners
California
-$2.49M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
EA
26
Emerald Advisers
Pennsylvania
$3.57M -$4.1M -56 -67%
Fidelity International
27
Fidelity International
Bermuda
$3.48M +$1.98M +27 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$3.41M -$146K -2 -7%
AIC
29
AWM Investment Company
New York
$3.27M +$1.83M +25 New
TCIM
30
TIAA CREF Investment Management
New York
$2.89M +$73.2K +1 +5%
Invesco
31
Invesco
Georgia
$2.46M -$952K -13 -41%
ARTA
32
A.R.T. Advisors
New York
$2.41M +$1.1M +15 +375%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$2.31M +$439K +6 +60%
BIM
34
BlackRock Investment Management
Delaware
$2.23M – – –
BCM
35
Bridgeway Capital Management
Texas
$2.22M – – –
BGA
36
Belmont Global Advisors
Texas
$2.21M +$366K +5 +42%
RCMC
37
RK Capital Management (Colorado)
Colorado
$2.19M +$1.24M +17 New
DCM
38
Driehaus Capital Management
Illinois
$2.11M +$1.17M +16 New
Renaissance Technologies
39
Renaissance Technologies
New York
$2.09M +$1.17M +16 New
Millennium Management
40
Millennium Management
New York
$1.99M +$1.1M +15 New
HCM
41
Howland Capital Management
Massachusetts
$1.97M -$293K -4 -21%
CS
42
Credit Suisse
Switzerland
$1.47M +$806K +11 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.26M – – –
Charles Schwab
44
Charles Schwab
California
$1.06M – – –
RFC
45
Russell Frank Company
Washington
$1.04M +$586K +8 New
GS
46
Gagnon Securities
New York
$1M -$1.03M -14 -64%
EI
47
EAM Investors
California
$982K +$586K +8 New
TA
48
Teachers Advisors
New York
$934K – – –
AQR Capital Management
49
AQR Capital Management
Connecticut
$907K +$513K +7 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$837K – – –
1
2
3 4

TPST Hedge Fund Activity: Q4 2014 in Review

73 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q4 2014, worth a combined $854M — up 250% from $244M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TPST positions and 3 closed out — a net gain of 22 holders — while 19 added to existing stakes and 14 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $18.5M. The largest seller was Deerfield Management, cutting an estimated $12.7M.

  • 73 institutional investors held Tempest Therapeutics (TPST) as of Q4 2014, up from 53 in Q3 2014.
  • Funds reported $854M of Tempest Therapeutics stock for Q4 2014, up 250% quarter-over-quarter.
  • 25 funds opened new Tempest Therapeutics positions in Q4 2014 and 3 closed out, a net change of +22 holders.
  • The largest Tempest Therapeutics buyer in Q4 2014 was Fidelity Investments, an estimated $18.5M added.
  • The largest Tempest Therapeutics seller in Q4 2014 was Deerfield Management, an estimated $12.7M sold.

Based on aggregated 13F filings for Q4 2014.